Literature DB >> 22348253

Brain tissue volumes in preterm infants: prematurity, perinatal risk factors and neurodevelopmental outcome: a systematic review.

K Keunen1, K J Kersbergen, F Groenendaal, I Isgum, L S de Vries, M J N L Benders.   

Abstract

OBJECTIVE: To evaluate the clinical value of neonatal brain tissue segmentation in preterm infants according to the literature.
METHODS: A structured literature search was undertaken in MEDLINE/Pubmed. This included all publications on volumetric brain tissue assessment in preterm infants at term-equivalent age (TEA) compared to brain tissue volumes of term-born infants, related to perinatal risk factors or related to neurodevelopmental outcome.
RESULTS: Sixteen prospective cohort studies, described in 30 articles, fulfilled the criteria. Preterm infants displayed total and regional brain tissue alterations compared to healthy, term-born controls. These alterations seemed more prominent with decreasing gestational age. White matter injury, intraventricular haemorrhage, postnatal corticosteroid therapy, intra-uterine growth retardation and chronic lung disease were frequently associated with volume changes. Associations between volume alterations at TEA and neurodevelopmental outcome in early childhood were shown in a few studies.
CONCLUSIONS: Preterm birth is associated with brain tissue volume alterations that become more pronounced in the presence of perinatal risk factors and white matter injury. Moreover, associations between volumetric alterations as early as TEA and long-term neurodevelopmental impairments are scarce.

Entities:  

Mesh:

Year:  2012        PMID: 22348253     DOI: 10.3109/14767058.2012.664343

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  34 in total

1.  The paradox of the preterm fetus.

Authors:  Suzanne L Miller
Journal:  J Physiol       Date:  2017-02-22       Impact factor: 5.182

2.  Neonatal imaging using an on-site small footprint MR scanner.

Authors:  Stephanie L Merhar; Jean A Tkach; Jason C Woods; Andrew P South; Emily L Wiland; Mantosh S Rattan; Charles L Dumoulin; Beth M Kline-Fath
Journal:  Pediatr Radiol       Date:  2017-05-03

3.  A New Ultrasound Marker for Bedside Monitoring of Preterm Brain Growth.

Authors:  J A Roelants; I V Koning; M M A Raets; S P Willemsen; M H Lequin; R P M Steegers-Theunissen; I K M Reiss; M J Vermeulen; P Govaert; J Dudink
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-17       Impact factor: 3.825

4.  Brain injury in premature neonates: A primary cerebral dysmaturation disorder?

Authors:  Stephen A Back; Steven P Miller
Journal:  Ann Neurol       Date:  2014-04-14       Impact factor: 10.422

Review 5.  Clinician performed ultrasound in fetal growth restriction: fetal, neonatal and pediatric aspects.

Authors:  A Sehgal; F Crispi; M R Skilton; W-P de Boode
Journal:  J Perinatol       Date:  2017-08-24       Impact factor: 2.521

Review 6.  Neuroprotection Strategies in Preterm Encephalopathy.

Authors:  Pratik Parikh; Sandra E Juul
Journal:  Semin Pediatr Neurol       Date:  2019-08-09       Impact factor: 1.636

7.  A point of care test for the determination of amniotic fluid interleukin-6 and the chemokine CXCL-10/IP-10.

Authors:  Piya Chaemsaithong; Roberto Romero; Steven J Korzeniewski; Zhong Dong; Lami Yeo; Sonia S Hassan; Yeon Mee Kim; Bo Hyun Yoon; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-10-20

Review 8.  Cerebral white and gray matter injury in newborns: new insights into pathophysiology and management.

Authors:  Stephen A Back
Journal:  Clin Perinatol       Date:  2014-03       Impact factor: 3.430

9.  Abnormal brain maturation in preterm neonates associated with adverse developmental outcomes.

Authors:  Vann Chau; Anne Synnes; Ruth E Grunau; Kenneth J Poskitt; Rollin Brant; Steven P Miller
Journal:  Neurology       Date:  2013-11-08       Impact factor: 9.910

10.  Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.

Authors:  Li-Jin Chew; Paolo Fusar-Poli; Thomas Schmitz
Journal:  Dev Neurosci       Date:  2013-02-27       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.